Selective Antitumor Effect of Shikonin Derived DMAKO-20 on Melanoma through CYP1B1.

Cui, Junqi; Zhou, Xiaobo; Huang, Jia; Cui, Jiahua; Chen, Jun

Cui, Junqi; Zhou, Xiaobo; Huang, Jia; Cui, Jiahua; Chen, Jun.

Afiliação

Cui J; Shanghai Ninth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute, Shanghai 200011. China.
Zhou X; Shanghai Ninth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute, Shanghai 200011. China.
Huang J; Shanghai Ninth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute, Shanghai 200011. China.
Cui J; School of Environmental Science and Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240. China.
Chen J; Shanghai Ninth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute, Shanghai 200011. China.

Curr Cancer Drug Targets ; 2020 Nov 15.

Article em En | MEDLINE | ID: mdl-33200710

Palavras-chave

Chemotherapy; Cytochrome P450; Melanoma; Prodrug; Shikonin; Skin Carcinoma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Curr Cancer Drug Targets Assunto da revista: ANTINEOPLASICOS / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google